Free Motion for Protective Order - District Court of Delaware - Delaware

Case 1:07-cv-00156-JJF Document 43 Filed 12/05/2007 Paget of 2
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
PDL BIOPHARMA, INC. )
Plaintiff, )
v. ) C. A. N0. 07-156 (***)
ALEXION PHARMACEUTICALS, INC., )
Defendant. g
JOINT MOTION FOR ENTRY OF ADDENDUM TO STIPULATED
CONFIDENTIALITY PROTECTIVE ORDER
Pursuant to Rule 26(c) of the Federal Rules of Civil Procedure, Plaintiff PDL
Biopharma, Inc. ("PDL") and Defendant Alexion Pharmaceuticals, Inc. ("Alexion")
jointly move this Court for entry of an Addendum to the Stipulated Confidentiality
Protective Order entered by the Court on September 5, 2007. (D.I. #31) The Addendum
is attached as Exhibit A.
In particular, the parties wish to clarify and, to the extent necessary, amend the
Stipulated Confidentiality Protective Order to allow Lonza Biologics, Inc. ("Lonza") to
designate its most confidential information in the same manner as specified for
documents to be designated "OUTSIDE ATTORNEYS AND CONSULTANTS ONLY"
by PDL and Alexion, under paragraph 3.2 of the Stipulated Confidentiality Protective
Order.
The Court is authorized by Rule 26(c)(7) to designate the manner in which "trade
secrets or other confidential research, development, or commercial information" may be
revealed. To facilitate the discovery of information from Lonza, Plaintiff and Defendant
respectfully move the Court to enter the proposed Addendum.

Case 1:07-cv-00156-JJF Document 43 Filed 12/05/2007 Page 2 of 2
Dated: December 5, 2007
Morris, Nichols, Arsht & Tunncll LLP Young, Conaway, Stargatt & Taylor, LLP
As/ Karen Jacobs Louden (#288/) /s/ Andrew A. Lundgren (#44292
Jack B. Blumenfeld (#1014) Josy W. Ingersoll (#1088)
Karen Jacobs Louden (#2881) Andrew A. Lundgren (#4429)
1201 N. Market Street The Brandywine Building
P.O. Box 1347 1000 West Street, 17th Floor
Wilmington, DE 19899-1347 P.O. Box 391
302-658-9200 Wilmington, DE 19899
[email protected] 302-571-6600
Attorneys for Plaint@’ and [email protected]
C0unter—Defendant Attorneys for Defendant and
PDL BioPharma, Inc. Counter-Claimant
Alexicn Pharmaceuticals, Inc.
OF COUNSEL: OF COUNSEL:
Weil, Gotshal & Manges LLP Kirkland & Ellis, LLP
Matthew D. Powers John Desmarais
Vernon Winters Gerald J. F lattmarm, Jr.
Eric Xanthopoulos Christine Willgoos
Silicon Valley Office Citigroup Center
201 Redwood Shores Parkway 153 East 53rd Street
Redwood Shores, California 94065 New York, New York 10022—4811
650-802—3000 212-446-4800
[email protected] [email protected]
Attorneys/or Plaintilfand Attorneysfor Defendant and
Counter- Defendant C0unter—Claimant
PDL Bi0Pharma, Inc. Alexion Pharmaceuticals, Inc.
2

Case 1:07-cv-00156-JJF Document 43-2 Filed 12/05/2007 Page1 of 2
EXHIBIT A

Case 1:07-cv-00156-JJF Document 43-2 Filed 12/05/2007 Page 2 of 2
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
PDL BIOPHARMA, INC. )
Plaintiff i
vi. g C. A. No. 07-156 (***)
ALEXION PHARMACEUTICALS, INC., i
Defendant. i
ADDENDUM TO STIPULATED CONFIDENTIALITY PROTECTIVE ORDER
Upon the motion of all parties pursuant to Rule 26(c) of the Federal Rules of Civil
Procedure it is hereby ORDERED that:
l. Paragraph 3.2 of the Stipulated Confidentiality Protective Order entered
into on September 5, 2007, shall be amended by inserting after "[i]nformation appropriate
for designation as OUTSIDE ATTORNEYS AND CONSULTANTS ONLY
presumptively include:"
· internal Lonza Biologics, Inc. ("Lonza") documents that have not been
exchanged with PDL or Alexion, except under written confidentiality
obligations that still apply to the materials;
2. The term "pa1ties," "PDL," "Alexion," or "Designating Party," included in
the Stipulated Confidentiality Protective Order entered into on September 5, 2007, shall
equally apply to Lonza so that the terms of the protective order apply to all Lonza
documents produced under this protective order.
SO ORDERED this day of December, 2007.
The Honorable Mary Pat Thynge
UNITED STATES MAGISTRATE JUDGE